Immucell's market cap is currently $54.82M. The company's EPS TTM is $0.056; its P/E ratio is 32.09; Immucell is scheduled to report earnings on August 14, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
